Genevieve Pussard Nee Contant

Title: Genevieve Pussard Nee Contant: Innovator in Plasminogen Research

Introduction

Genevieve Pussard Nee Contant is a notable inventor based in Courbevoie, France. She has made significant contributions to the field of biochemistry, particularly in the determination of plasminogen activators and their inhibitors. Her innovative work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Genevieve holds a patent for a method of determining a plasminogen activator and its inhibitor. The patent describes the use of a substance that inhibits the plasma proteins α2-AP and/or α2-M in the determination and assay of plasminogen activators. Specifically, her method involves converting plasminogen to plasmin and assaying the resulting plasmin while inhibiting the plasma proteins α2-antiplasmin and/or α2-macroglobulin using metalloproteinase materials. This invention is crucial for advancing the understanding and treatment of conditions related to blood clotting.

Career Highlights

Genevieve is associated with Serbio, a company that focuses on innovative solutions in the field of biochemistry. Her work at Serbio has allowed her to explore and develop methods that enhance the accuracy of plasminogen assays, contributing to better diagnostic tools in healthcare.

Collaborations

Genevieve has collaborated with esteemed colleagues such as Jean-Luc Martinolli and Gerad Quentin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the scientific community.

Conclusion

Genevieve Pussard Nee Contant is a pioneering inventor whose work in plasminogen research has the potential to impact medical diagnostics significantly. Her contributions reflect the importance of innovation in advancing healthcare solutions.